Qualigen Therapeutics, Inc. (QLGN)

Latest Insider Confidence Score

2025Q4

50.0
Bullish

Company insider confidence (by quarter)

2015Q2 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Javelin Venture Partners, L.P. 10% Owner 5,000,000 Oct 27, 2017
Sekisui Diagnostics, Llc — 1,980,233 May 27, 2020
Stonehenge Partners LLC — 817,272 Jun 30, 2015
Ritter Andrew J CEO 583,068 May 19, 2020
Step Michael D CEO 495,065 Jan 25, 2018

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 5, 2025 Wang Jiawei CEO Neutral 52.5 - 0.00% ✗ -
Nov 15, 2024 Bensler Graydon Director Neutral 52.5 - 0.00% ✗ -
Oct 17, 2024 Braeden Lichti Director Neutral 52.5 - 0.00% ✗ -
Aug 9, 2024 LIM ROBERT BRADLEY Director Neutral 52.5 - 0.00% ✗ -
Aug 9, 2024 BECHER CAMPBELL Director Neutral 52.5 - 0.00% ✗ -
Jul 25, 2024 PRICE CODY Director Neutral 52.5 - 0.00% ✗ -
Jul 11, 2022 Aug 4, 2022 Abdul-Ahad Wajdi President Neutral 52.5 - 0.00% ✗ -
Jul 11, 2022 Aug 4, 2022 Lotz Christopher L. CFO Neutral 52.5 - 0.00% ✗ -
Jul 11, 2022 Aug 4, 2022 ARSHAD TARIQ SVP/Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jul 11, 2022 Aug 4, 2022 Ritter Ira E. Director Neutral 52.5 - 0.00% ✗ -
Jul 11, 2022 Aug 4, 2022 EMERY SIDNEY W JR Director Neutral 52.5 - 0.00% ✗ -
Jul 11, 2022 Aug 4, 2022 Kruger Kurt H Director Neutral 52.5 - 0.00% ✗ -
Jul 11, 2022 Aug 4, 2022 David Richard A. Director Neutral 52.5 - 0.00% ✗ -
Jul 11, 2022 Aug 4, 2022 Sinha Shishir K. COO Neutral 52.5 - 0.00% ✗ -
Jul 11, 2022 Aug 4, 2022 Poirier Michael S. CEO Neutral 52.5 - 0.00% ✗ -
Jul 11, 2022 Aug 4, 2022 Korenberg Matthew E Director Neutral 52.5 - 0.00% ✗ -
Jul 11, 2022 Aug 4, 2022 BROIDRICK AMY S. President Neutral 52.5 - 0.00% ✗ -
Jun 22, 2022 Jun 22, 2022 Poirier Michael S. CEO Buy 91.3 +30,000 16.65% ✗ $17.1K
Jun 14, 2022 Jun 15, 2022 BROIDRICK AMY S. President Buy 91.3 +30,000 666.67% ✗ $18.6K
Dec 8, 2021 Dec 10, 2021 BROIDRICK AMY S. President Neutral 52.5 - 0.00% ✗ -
Dec 8, 2021 Dec 10, 2021 ARSHAD TARIQ SVP/Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Aug 19, 2021 Aug 20, 2021 Kruger Kurt H Director Buy 90.0 +8,000 80.00% ✗ $9.8K
May 17, 2021 May 18, 2021 ARSHAD TARIQ SVP/Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
May 17, 2021 ARSHAD TARIQ SVP/Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Apr 26, 2021 Apr 26, 2021 BROIDRICK AMY S. EVP, Chief Strategy Officer Buy 90.0 +4,500 100.00% ✗ $9.1K
Apr 20, 2021 Apr 21, 2021 Poirier Michael S. CEO Buy 86.3 +11,005 6.50% ✗ $19.8K
Apr 16, 2021 Apr 19, 2021 Lotz Christopher L. CFO Buy 90.0 +2,700 27.44% ✗ $5K
Dec 29, 2020 Dec 30, 2020 Kruger Kurt H Director Buy 91.3 +4,000 66.67% ✗ $11.7K
Dec 7, 2020 Dec 29, 2020 BROIDRICK AMY S. Executive VP, CSO Neutral 52.5 - 0.00% ✗ -
Dec 7, 2020 Dec 8, 2020 EMERY SIDNEY W JR Director Neutral 52.5 - 0.00% ✗ -
Dec 7, 2020 EMERY SIDNEY W JR Director Neutral 52.5 - 0.00% ✗ -
Nov 20, 2020 Nov 23, 2020 Kruger Kurt H Director Buy 91.3 +6,000 100.00% ✗ $20.9K
Aug 27, 2020 Aug 28, 2020 BROIDRICK AMY S. Director Neutral 52.5 - 0.00% ✗ -
Aug 28, 2020 BROIDRICK AMY S. Director Neutral 52.5 - 0.00% ✗ -
Aug 5, 2020 SEKISUI DIAGNOSTICS, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Jun 6, 2020 Jun 8, 2020 Ritter Ira E. Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2020 Jun 8, 2020 David Richard A. Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2020 Jun 8, 2020 Poirier Michael S. CEO Neutral 52.5 - 0.00% ✗ -
Jun 6, 2020 Jun 8, 2020 Abdul-Ahad Wajdi President Neutral 52.5 - 0.00% ✗ -
Jun 6, 2020 Jun 8, 2020 Kruger Kurt H Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2020 Jun 8, 2020 Sinha Shishir K. President Neutral 52.5 - 0.00% ✗ -
Jun 6, 2020 Jun 8, 2020 Korenberg Matthew E Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2020 Jun 8, 2020 Lotz Christopher L. CFO Neutral 52.5 - 0.00% ✗ -
May 27, 2020 SEKISUI DIAGNOSTICS, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
May 22, 2020 May 27, 2020 Abdul-Ahad Wajdi VP, R&D, CSO Neutral 52.5 - 0.00% ✗ -
May 22, 2020 May 27, 2020 Sinha Shishir K. President Neutral 52.5 - 0.00% ✗ -
May 22, 2020 May 27, 2020 Poirier Michael S. CEO Neutral 90.0 +169,192 100.00% ✗ -
May 22, 2020 May 27, 2020 Lotz Christopher L. CFO Neutral 90.0 +9,841 100.00% ✗ -
May 22, 2020 May 27, 2020 Kruger Kurt H Director Neutral 52.5 - 0.00% ✗ -
May 22, 2020 May 27, 2020 David Richard A. Director Neutral 52.5 - 0.00% ✗ -
May 27, 2020 Poirier Michael S. CEO Neutral 52.5 - 0.00% ✗ -
May 27, 2020 Sinha Shishir K. VP of Operations Neutral 52.5 - 0.00% ✗ -
May 27, 2020 Korenberg Matthew E Director Neutral 52.5 - 0.00% ✗ -
May 27, 2020 Lotz Christopher L. CFO Neutral 52.5 - 0.00% ✗ -
May 27, 2020 Kruger Kurt H Director Neutral 52.5 - 0.00% ✗ -
May 27, 2020 David Richard A. Director Neutral 52.5 - 0.00% ✗ -
May 27, 2020 Abdul-Ahad Wajdi VP, R&D, CSO Neutral 52.5 - 0.00% ✗ -
May 18, 2020 May 19, 2020 Ritter Ira E. COB, CSO Neutral 52.5 - 0.00% ✗ -
May 18, 2020 May 19, 2020 Beck John W CFO Neutral 52.5 - 0.00% ✗ -
May 18, 2020 May 19, 2020 Ritter Andrew J CEO Neutral 52.5 - 0.00% ✗ -
Jan 21, 2020 Apr 23, 2020 FOEHR MATTHEW W Director Neutral 90.0 +38,461 38.39% ✗ -
Mar 12, 2020 Mar 16, 2020 Doyle Noah Director Sell 22.5 -500,000 -40.34% ✗ $110K
Mar 4, 2020 Mar 13, 2020 Ritter Ira E. COB, CSO Sell 27.5 -18,750 -18.55% ✗ $7K
Mar 4, 2020 Mar 13, 2020 Ritter Andrew J CEO Sell 27.5 -18,750 -18.55% ✗ $7K
Feb 25, 2020 Feb 27, 2020 Doyle Noah Director Neutral 52.5 - 0.00% ✗ -
Jan 15, 2020 Jan 17, 2020 FOEHR MATTHEW W Director Neutral 52.5 - 0.00% ✗ -
Jan 15, 2020 Jan 17, 2020 Merino William M. Director Neutral 52.5 - 0.00% ✗ -
Jan 15, 2020 Jan 17, 2020 MAIER PAUL V Director Neutral 52.5 - 0.00% ✗ -
Jan 15, 2020 Jan 17, 2020 Doyle Noah Director Neutral 52.5 - 0.00% ✗ -
Feb 6, 2019 Feb 8, 2019 FOEHR MATTHEW W Director Neutral 52.5 - 0.00% ✗ -
Feb 6, 2019 Feb 8, 2019 Doyle Noah Director Neutral 52.5 - 0.00% ✗ -
Feb 6, 2019 Feb 8, 2019 Merino William M. Director Neutral 52.5 - 0.00% ✗ -
Feb 6, 2019 Feb 8, 2019 Merino William M. Director Neutral 52.5 - 0.00% ✗ -
Feb 6, 2019 Feb 8, 2019 MAIER PAUL V Director Neutral 52.5 - 0.00% ✗ -
Feb 6, 2019 Feb 8, 2019 Beck John W CFO Neutral 52.5 - 0.00% ✗ -
Feb 6, 2019 Feb 8, 2019 Ritter Ira E. COB, CSO Neutral 52.5 - 0.00% ✗ -
Feb 6, 2019 Feb 8, 2019 Ritter Andrew J CEO Neutral 52.5 - 0.00% ✗ -
Nov 5, 2018 Nov 7, 2018 FOEHR MATTHEW W Director Neutral 52.5 - 0.00% ✗ -
Aug 17, 2018 Sep 19, 2018 FOEHR MATTHEW W Director Buy 91.3 +19,751 564.31% ✗ $40.3K
Aug 17, 2018 Aug 20, 2018 FOEHR MATTHEW W Director Buy 91.3 +19,751 56.43% ✗ $40.3K
Jun 26, 2018 Jun 27, 2018 Ritter Andrew J CEO Neutral 52.5 - 0.00% ✗ -
May 23, 2018 May 25, 2018 Beck John W CFO Neutral 52.5 - 0.00% ✗ -
May 25, 2018 Beck John W CFO Neutral 52.5 - 0.00% ✗ -
Jan 23, 2018 Jan 25, 2018 PROEHL GERALD T Director Neutral 52.5 - 0.00% ✗ -
Jan 23, 2018 Jan 25, 2018 Doyle Noah Director Neutral 52.5 - 0.00% ✗ -
Jan 23, 2018 Jan 25, 2018 MAIER PAUL V Director Neutral 52.5 - 0.00% ✗ -
Jan 23, 2018 Jan 25, 2018 FOEHR MATTHEW W Director Neutral 52.5 - 0.00% ✗ -
Jan 23, 2018 Jan 25, 2018 Merino William M. Director Neutral 52.5 - 0.00% ✗ -
Jan 23, 2018 Jan 25, 2018 Step Michael D CEO Neutral 52.5 - 0.00% ✗ -
Jan 23, 2018 Jan 25, 2018 Ritter Andrew J President Neutral 52.5 - 0.00% ✗ -
Jan 23, 2018 Jan 25, 2018 Ritter Ira E. Chair Neutral 52.5 - 0.00% ✗ -
Jan 23, 2018 Jan 25, 2018 Benjamin Jeffrey S VP of Finance Neutral 52.5 - 0.00% ✗ -
Oct 3, 2017 Oct 27, 2017 Ritter Andrew J President Neutral 90.0 +187,500 22.77% ✗ -
Oct 3, 2017 Oct 27, 2017 Ritter Ira E. Chair Neutral 90.0 +187,500 22.77% ✗ -
Oct 3, 2017 Oct 27, 2017 Doyle Noah Director Neutral 90.0 +5,000,000 208.92% ✗ -
Oct 3, 2017 Oct 27, 2017 Javelin Venture Partners, L.P. 10% Owner Neutral 90.0 +5,000,000 244.16% ✗ -
Oct 23, 2017 Benjamin Jeffrey S VP of Finance Neutral 52.5 - 0.00% ✗ -
May 18, 2017 May 18, 2017 FOEHR MATTHEW W Director Buy 91.3 +18,000 105.88% ✗ $11.2K
May 11, 2017 May 12, 2017 Step Michael D CEO Buy 90.0 +13,000 35.14% ✗ $8K
Feb 27, 2017 Feb 28, 2017 Step Michael D CEO Buy 91.3 +10,000 37.04% ✗ $26.5K